Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report)’s stock price fell 3.8% during trading on Wednesday . The stock traded as low as C$0.25 and last traded at C$0.26. 384,329 shares changed hands during trading, a decline of 40% from the average session volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Performance
The firm has a market cap of C$52.28 million and a P/E ratio of -0.37. The company has a current ratio of 2.97, a quick ratio of 2.61 and a debt-to-equity ratio of 35.45. The company’s 50-day moving average is C$0.26 and its two-hundred day moving average is C$0.26.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Featured Articles
- Five stocks we like better than Emerald Health Therapeutics
- Compound Interest and Why It Matters When Investing
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is a Death Cross in Stocks?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Most active stocks: Dollar volume vs share volume
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
